Word

AGOS

Status

Registered

Status Code

700

Status Date

Tuesday, May 11, 2021

Serial Number

88718586

Registration Number

6344572

Registration Date

Tuesday, May 11, 2021

Mark Type

4000

Filing Date

Friday, December 6, 2019

Published for Opposition

Tuesday, February 23, 2021

Trademark Owner History

Agos Healthcare Limited - Original Registrant

Classifications

9 Downloadable and recorded computer software for use as a database and for analysing data in the fields of pharmaceuticals, clinical trials, clinical research and biotechnology; Downloadable software applications for computers, laptops and mobile phones featuring software for use as a database and for collating, storing, analysing, and utilizing data in the fields of pharmaceuticals, clinical trials, clinical research and biotechnology; Downloadable and recorded software for secure data storage and retrieval and transmission of customer and client information; Downloadable and recorded computer software for use as a database and for collating, storing, analysing and utilizing data in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; downloadable and recorded computer operating programs and downloadable and recorded application development software for use on or in connection with mobile phones, tablets and handheld devices in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; data processing equipment and computers; Downloadable electronic publications in the nature of e-books, magazines, newsletters and reports provided on-line from a database or the internet in the fields of pharmaceuticals, clinical trials, clinical research and biotechnology

38 Providing Internet access, namely, providing access to platforms and portals on the internet in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; providing user access to global computer networks, namely, providing user access to platforms and portals on the internet in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; information, advice and consultancy services in relation to all the aforesaid services

35 Business project and risk management services in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; business consultancy services; Business project and risk management and consultancy services in the field of clinical trials and clinical research; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management services for medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; providing business information management services on clinical trials and clinical research; providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; providing business management information in connection with consultancy and advisory services in the field of strategic planning; regulatory submission management, namely, business strategic planning, and preparing and submitting applications for others for new medical devices, new pharmaceuticals, variations on previously approved medical devices, and variations on previously approved pharmaceuticals to receive clinical trial approval or marketing authorization from governmental regulatory bodies; regulatory submission management, namely, assisting others with strategic business planning, and preparing and filing applications with governmental regulatory bodies for approval of new medical devices and new pharmaceuticals; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; New pharmaceutical and biotechnology product commercialization services; consultancy services for others in the field of new pharmaceutical and biotechnology product commercialization; information, advice and consultancy services in relation to all the aforesaid services

44 Managed healthcare services being medical services in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; consultancy services in the field of medical information services; medical consultancy services in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; consultancy services in the field of biotechnology diagnostics and pharmacogenetics diagnostics medical testing; medical information, advice and consultancy services in the pharmaceutical and healthcare sectors; medical information, advice and consultancy services in relation to pharmacovigilance; information, advice and consultancy services in relation to all the aforesaid services

42 Providing medical and scientific research information in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; Product and scientific research and development in the field of pharmaceuticals, clinical trials, clinical research, medical devices and biotechnology; Consultancy services for others in the field of technical consultancy for pharmaceuticals, design, planning, and implementation consultancy for clinical trials, consultancy on scientific clinical research, and design and development consultancy for medical devices; conducting early evaluations in the field of new pharmaceuticals; consultancy services in the field of design, planning, implementation and project management of clinical trials, pharmacovigilance, pharmaceutical and biotechnology product development; consultancy services in the fields of biotechnology, pharmaceutical research and development, laboratory testing and pharmacogenetics; medical and scientific research; conducting clinical trials for others; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research and development; product development consultancy in the field of pharmaceuticals and biotechnology; testing and quality control evaluation of products in the field of pharmaceuticals, clinical trials and biotechnology; product testing and quality control evaluation of pharmaceutical preparations and medicines; testing and quality control in the nature of conducting clinical trials in the field of pharmaceuticals and biotechnology for others; Software as a Service (SaaS) featuring software for use as a database and for analysing data in the fields of in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; providing online non-downloadable software applications for use in creating, designing, hosting, publishing, managing and maintaining content for use on the internet for website and media content management purposes; application service provider featuring application programming interface (API) software to allow people to view data through an interactive map, to query data, to generate reports and to access data and documents; software as a service (SAAS) featuring computer software to enable the displaying, receiving and transmitting of data to enable the purchase of goods and services; information, advice and consultancy services in relation to all the aforesaid services

The wording "AGOS" has no meaning in a foreign language.

Trademark Events

May 11, 2021

Registered-Principal Register

Feb 23, 2021

Official Gazette Publication Confirmation E-Mailed

Feb 23, 2021

Published For Opposition

Feb 3, 2021

Notification Of Notice Of Publication E-Mailed

Jan 21, 2021

Approved For Pub - Principal Register

Jan 21, 2021

Examiner's Amendment Entered

Jan 21, 2021

Notification Of Examiners Amendment E-Mailed

Jan 21, 2021

Examiners Amendment E-Mailed

Jan 21, 2021

Examiners Amendment -Written

Jan 19, 2021

Teas/Email Correspondence Entered

Jan 19, 2021

Correspondence Received In Law Office

Jan 19, 2021

Teas Request For Reconsideration Received

Oct 26, 2020

Notification Of Final Refusal Emailed

Oct 26, 2020

Final Refusal E-Mailed

Oct 26, 2020

Final Refusal Written

Oct 20, 2020

Teas/Email Correspondence Entered

Oct 20, 2020

Correspondence Received In Law Office

Oct 19, 2020

Assigned To Lie

Sep 3, 2020

Teas Response To Office Action Received

Mar 9, 2020

Notification Of Non-Final Action E-Mailed

Mar 9, 2020

Non-Final Action E-Mailed

Mar 9, 2020

Non-Final Action Written

Mar 6, 2020

Assigned To Examiner

Dec 11, 2019

New Application Office Supplied Data Entered

Dec 10, 2019

New Application Entered